课题基金 / 基金详情

Developmental impact of MLL-AF4fusion gene on early hematopoieticstem cells

Developmental impact of MLL-AF4fusion gene on early hematopoieticstem cells
MLL-AF4融合基因对早期造血干细胞发育的影响
批准号:
22591162
负责人:
EGUCHI Mariko
金额:
$2.91万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2010
资助国家:
日本
项目状态:
已结题
起止时间:
2010 至 2012

项目摘要

项目成果

EGUCHI Mariko的其他基金

相似基金

相关文献

中文摘要
翻译
为了研究MLL-AF4融合基因对早期造血发育的影响,我们构建了MLL-AF4组成表达的小鼠胚胎干细胞(ES)。当通过胚状体(EB)形成检测造血分化时,与对照Ebs相比,含有早期造血干细胞的Tie2^+c-kit^+细胞在表达MLL-AF4的Ebs中显著减少。表达阵列分析表明MLL-AF4作为基因表达的正调控因子上调了多种基因的表达。已知MLL-AF4上调的几个基因在细胞向间充质谱系分化的过程中起重要作用,而造血谱系的转录调节因子则下调。这些表达MLL-AF4的造血前干细胞具有间充质性质,在体外不能引起白血病,表明一些继发性事件是引起白血病的必要条件。MLL-AF4具有影响早期造血细胞分化的潜力,当伴随着一些重要的额外遗传事件时,可能导致白血病转化。
英文摘要
To study the developmental impact of MLL-AF4 fusion gene on early hematopoietic development, mouse embryonic stem (ES) cells with constitutive expression of MLL-AF4 were established. When hematopoietic differentiation was examined by embryoid body (EB) formation, Tie2^+c-kit^+cells which contain early hematopoietic stem cells were significantly reduced in MLL-AF4 expressing Ebs compared to that of control Ebs.Expression array analysis indicated that MLL-AF4 works as positive regulator of gene expression up-regulating various genes. Several genes up-regulated by MLL-AF4 were known to have important roles in cell differentiation to mesenchymal lineage, whereas transcriptional regulator of hematopoietic lineage were down-regulated. These MLL-AF4 expressing pre-hematopoietic stem cells with mesenchymal nature, were unable to cause leukemia in vitroor in vivo, showing that some secondary event is necessary to cause leukemia. MLL-AF4, having the potential to influence early hematopoietic cell differentiation, may cause leukemic transformation whenaccompanied by some important additional genetic events.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
小児白血病とTEL遺伝子異常
儿童白血病和 TEL 基因异常
DOI: --
发表时间: 2011
期刊: 臨床血液
影响因子: --
作者: [江口真理子, 石前峰斉]
通讯作者: 石前峰斉
DOI: 10.1016/j.cancergencyto.2010.07.121
发表时间: 2010-10-01
期刊: CANCER GENETICS AND CYTOGENETICS
影响因子: --
作者: [Otsubo, Keisuke, Kanegane, Hirokazu, Miyawaki, Toshio]
通讯作者: Miyawaki, Toshio
DOI: 10.1111/j.1399-3038.2012.01282.x
发表时间: 2012-08-01
期刊: PEDIATRIC ALLERGY AND IMMUNOLOGY
影响因子: 4.4
作者: [Kanegane, Hirokazu, Yang, Xi, Miyawaki, Toshio]
通讯作者: Miyawaki, Toshio
リンパ球機能異常と類縁疾患 原発性免疫不全症候群Ataxia-telangiectasia、日本臨床別冊 血液症候群(第2版)II -その他の血液疾患を含めて
淋巴细胞功能异常及相关疾病原发性免疫缺陷综合症共济失调毛细血管扩张症,日本临床特别版血液综合症(第二版)II - 包括其他血液疾病
DOI: --
发表时间: 2013
期刊:
影响因子: --
作者: [石前峰斉, 江口真理子]
通讯作者: 江口真理子
31
    The Interaction among Non-native Speakers in Light of Participants' Cultures
    • 批准号:
      24520634
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2012
    • 负责人:
      EGUCHI Mariko
    • 依托单位:
    The role of TEL in embryonic stem cell differentiation, and identification of a new interacting protein.
    Environmental Approaches to the Advertising Magic to Create Desires
    • 批准号:
      17530380
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.4万
    • 财政年份:
      2005
    • 负责人:
      EGUCHI Mariko
    • 依托单位:
    Wartime Advertising and Propaganda toward East Asian Countries
    • 批准号:
      14310173
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $2.37万
    • 财政年份:
      2002
    • 负责人:
      EGUCHI Mariko
    • 依托单位:
    国内基金
    海外基金
    MEN1 失活通过 PCP4/NR2F6/MLL1轴调控 MGMT 影响胰腺神经内分泌瘤替莫唑胺化疗耐药的机制研究
    • 批准号:
      25TS1403500
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      吉顺荣
    • 依托单位:
    MEN1失活通过PCP4/NR2F6/MLL1轴调控MGMT影响胰腺神经内分泌瘤替莫唑胺化疗耐药的机制研究
    • 批准号:
      25TS1403500
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      吉顺荣
    • 依托单位:
    LncRNA-LAPR/LAMP5调控MLL融合蛋白经自噬-溶酶体降 解在MLL重排AML发生发展中的作用机制研究
    MLL3/GRHL2/IRF1轴失调促进食管鳞癌免疫逃逸的分子机制
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      15.0万元
    • 批准年份:
      2024
    • 负责人:
      黄国韦
    • 依托单位: